<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name><gtr:address><gtr:line1>BBSRC</gtr:line1><gtr:line2>Polaris House</gtr:line2><gtr:line3>North Star Avenue</gtr:line3><gtr:line4>Swindon</gtr:line4><gtr:postCode>SN2 1UH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/3D9B6C4A-63ED-4A5C-9767-0F868A64CA6D"><gtr:id>3D9B6C4A-63ED-4A5C-9767-0F868A64CA6D</gtr:id><gtr:firstName>Terence</gtr:firstName><gtr:surname>Davis</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D09AE664-41EE-4980-B9DB-36942A07FC83"><gtr:id>D09AE664-41EE-4980-B9DB-36942A07FC83</gtr:id><gtr:firstName>Mark Christopher</gtr:firstName><gtr:surname>Bagley</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9E84E69-2A45-4348-9C8B-19FB6204B740"><gtr:id>C9E84E69-2A45-4348-9C8B-19FB6204B740</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Kipling</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/494FFECE-9B26-4246-BA44-D1AA490A1853"><gtr:id>494FFECE-9B26-4246-BA44-D1AA490A1853</gtr:id><gtr:firstName>Joanna</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Latimer</gtr:surname><gtr:orcidId>0000-0001-7418-7515</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=ES%2FG037205%2F1"><gtr:id>BE9829F9-26F2-479B-92ED-2D37A7D2CC5D</gtr:id><gtr:title>A combined genetic and small molecule approach to studying the role of the p38/MK2 stress signalling pathway in a human premature ageing syndrome</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>ES/G037205/1</gtr:grantReference><gtr:abstractText>&lt;p>There is now an increasing realisation that an improved understanding of the biology of normal ageing will give important insights into what is a major risk factor for many age-related diseases - age itself.&amp;nbsp;&lt;/p>

&lt;p>This programme will study accelerated ageing in a rare human genetic disease called Werner syndrome (WS).&amp;nbsp; WS is associated with more rapid ageing at the cellular level.&amp;nbsp; If premature cell ageing underlies the premature ageing of WS individuals, the study of WS may aid in the understanding of not only how cellular processes lead to human ageing, but also in the pathology of age-related diseases.&amp;nbsp;&lt;/p>

&lt;p>It will use a combination of genetic modification and chemical drugs to study a key stress-signalling pathway and provide direct interventional evidence regarding its role in premature ageing.&amp;nbsp; This in turn raises a number of important issues regarding the use of true &amp;quot;anti-ageing&amp;quot; medicines.&amp;nbsp; Until recently such drugs (which target symptoms of ageing but not overt disease) have largely been the realms of fantasy.&amp;nbsp; However, recent progress has now raised the very real possibility of direct clinical intervention in aspects of the ageing process.&lt;/p>

&lt;p>This programme will also take the first steps to engage with this societal issue.&lt;br />&lt;/p></gtr:abstractText><gtr:fund><gtr:end>2012-12-26</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/924BE15C-91F2-4AAD-941A-3F338324B6AE"><gtr:id>924BE15C-91F2-4AAD-941A-3F338324B6AE</gtr:id><gtr:name>ESRC</gtr:name></gtr:funder><gtr:start>2009-06-26</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>258764</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Stress, senescence and premature ageing</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>C08D3196-D26F-44AF-8A4E-C07B42E60650</gtr:id><gtr:impact>Invited Lecture</gtr:impact><gtr:outcomeId>r-7544274635.1885372b207810</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Social justice and (Anti)-Ageing Science and Medicine.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>904FCD8E-2D5C-4EC4-9EA4-FCC562F67316</gtr:id><gtr:impact>Paper presented at a seminar

Section not completed</gtr:impact><gtr:outcomeId>r-1894162448.02452872b5fe464</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Towards a cure for adult progeria</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8F3EC8D0-F07E-4ACB-B7E7-0F36979A5CEE</gtr:id><gtr:impact>Presentation on research findings concerning the role of stress signalling on premature ageing syndromes and progress towards a cure.</gtr:impact><gtr:outcomeId>r-9137125936.4645232b18267e</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Assessing the role of p38 MAP kinase activity in replicative senescence in fibroblasts from progeroid syndromes.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>BCB911FE-BEF7-4475-80E0-66DE2A1CAA61</gtr:id><gtr:impact>Poster presentation at the 61st Annual Scientific Meeting of the British Society for Research on Ageing / 14th Congress of the International Association of Biomedical Gerontology Conference: The Science of Ageing; Global Progress.</gtr:impact><gtr:outcomeId>r-6956368551.5489142a90ce90</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>A New Dynamic of Ageing: The NDA Programme and Age UK Research Showcase of the Decade</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E8139790-B7FD-4533-8A5B-D06D87D5BA0E</gtr:id><gtr:impact>A one day event to showcase research findings to policy makers and stakeholders, held at the Business Design Centre London on 21st October 2013</gtr:impact><gtr:outcomeId>r-9994033379.4746862aebe668</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The role of p38MAPK in the premature ageing of skin fibroblasts</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>68732721-8FB5-4A63-A11A-3589954AE57A</gtr:id><gtr:impact>Invited Lecture at the British Association of Dermatologists' Conference 'Ageing Skin: Insights and Interventions'</gtr:impact><gtr:outcomeId>r-7280947759.0778362b207a18</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Replicative senescence and human ageing processes</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>69B89C42-31E1-4C31-B4BE-2B6040EC4981</gtr:id><gtr:impact>A network poster presented at 'Promoting Active and Healthy Ageing' Conference organised by Cardiff University Ageing, Science and Older People (CASciOPe) network to celebrate the United Nations International Day of Older People.</gtr:impact><gtr:outcomeId>r-4869015724.2762072af474b8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stress Senescence and premature ageing</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>41591688-A9F3-4D48-AD3A-DB3316C3D790</gtr:id><gtr:impact>Invited Lecture</gtr:impact><gtr:outcomeId>r-9982754271.46142b207914</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Replication stress and ageing in Werner and ATR-Seckel syndrome fibroblasts.</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>EFABA959-7A9F-4B8F-BCD9-D12073E9B011</gtr:id><gtr:impact>A poster presented at the 8th European Congress of Biogerontology Conference 'Healthy Ageing and Regenerative Medicine' organised by the Ben Gurion University of the Negev Israel.</gtr:impact><gtr:outcomeId>r-9063248260.9369322a9c4946</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cell senescence and telomeres in the context of cancer and human ageing</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>BC63649A-4D09-4A23-BFFD-43B97522D62A</gtr:id><gtr:impact>University of Suffolk Seminar Series</gtr:impact><gtr:outcomeId>r-5912873070.6059122b2076e4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Intimations of (Im)mortality: how aging scientists debate the relation between the normal, the natural and the pathological</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>D058DED9-8464-4C1E-BB0D-7D41D3ADDFF9</gtr:id><gtr:impact>Keynote Presentation @ BSA Ageing Body and Society Study Group, Future of Ageing, Science Technology &amp;amp; the Body. British Library, London.</gtr:impact><gtr:outcomeId>r-3039902060.32982252ac9e900</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Werner syndrome and the role of stress signalling in cellular ageing</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>BF8D3CD9-12DA-4DD4-9AA0-BD639B10D037</gtr:id><gtr:impact>Presentation of research findings at the British Society for Research on Ageing annual scientific meeting Ageing Mechanisms and Mitigants. Birmingham, UK.</gtr:impact><gtr:outcomeId>r-8142153190.581272b182552</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Towards therapeutic intervention in human premature ageing syndromes</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>800FC80A-D640-4B83-98D9-A24CBA19BED4</gtr:id><gtr:impact>Presentation on current progress towards intervening in cellular ageing in premature ageing syndromes</gtr:impact><gtr:outcomeId>r-1259170417.91525722b182926</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>635000</gtr:amountPounds><gtr:country>Kazakhstan, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Identification of small molecules capable of removing ageing cells and slowing down the ageing process</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Ministry of education and science of the Republic of Kazakhstan</gtr:fundingOrg><gtr:fundingRef>#83</gtr:fundingRef><gtr:id>2E014E08-91E8-4A07-87A0-4B4451D17AA4</gtr:id><gtr:outcomeId>5ef244ac5ef244c0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>They have been used by other scientists studying ageing.</gtr:description><gtr:firstYearOfImpact>2011</gtr:firstYearOfImpact><gtr:id>281A9157-43A7-4A5A-A146-A8B4B8DD563E</gtr:id><gtr:impactTypes/><gtr:outcomeId>544504a82ea120.39546399</gtr:outcomeId><gtr:sector>Chemicals,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This programme studied the premature ageing Werner syndrome (WS) that provides a powerful model system to study human ageing biology. WS is associated with rapid cell ageing, in particular acceleration of replicative senescence (the ageing of dividing cells). We previously identified a role for stress-signalling in this accelerated cell ageing involving p38 MAP kinase that also regulates the production of proinflammatory molecules such as cytokines, high levels of which are associated with diseases such as osteoporosis and type II diabetes that are more common in WS. As therapeutic targeting of p38 is problematic due to toxicity issues, we wished to further refine this stress pathway by examining the role of the downstream target MK2 in cell ageing. 

 

Using genetic modification and chemical drugs to target MK2, we asked whether MK2 inhibition prevents (or delays) cell ageing in cells from WS and non-WS individuals. We found that cell growth rates of immortal WS cells were not affected, whereas p38 inhibition increased growth rates; however, the stressed morphology of WS cells was corrected. Growth rates of mortal (primary) WS or non-WS cells were also not affected, but the stressed morphology of primary WS cells was corrected. The replicative capacity was increased for both WS and non-WS cells. Finally, MK2 inhibitors did not prevent stress-induced cell senescence. These data suggest that MK2 is not involved in stress-induced cell senescence, and add to our understanding of how cellular senescence may lead to in vivo human ageing and in the pathology of age-related inflammatory diseases.</gtr:description><gtr:exploitationPathways>It will inform future attempts to study the interaction between inflammation and ageing and future therapies targeting ageing mechanisms</gtr:exploitationPathways><gtr:id>23C6B4F1-D36C-4A53-B304-D8276920F838</gtr:id><gtr:outcomeId>r-6016006214.559084b2f189b8</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Security and Diplomacy,Transport,Other</gtr:sector></gtr:sectors><gtr:url>http://www.newdynamics.group.shef.ac.uk/stress-and-immunity.html</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BE27925C-6EA8-4890-9CAB-9094A54B96A4</gtr:id><gtr:title>Use of p38 MAPK Inhibitors for the Treatment of Werner Syndrome.</gtr:title><gtr:parentPublicationTitle>Pharmaceuticals (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b56f28666e97438b7e93beed50afe57"><gtr:id>3b56f28666e97438b7e93beed50afe57</gtr:id><gtr:otherNames>Bagley MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1424-8247</gtr:issn><gtr:outcomeId>doi_53cfaefaea378fea</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F38BCAD7-E719-4A77-A23D-849A4058E1F6</gtr:id><gtr:title>Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells.</gtr:title><gtr:parentPublicationTitle>Pharmaceuticals (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b56f28666e97438b7e93beed50afe57"><gtr:id>3b56f28666e97438b7e93beed50afe57</gtr:id><gtr:otherNames>Bagley MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1424-8247</gtr:issn><gtr:outcomeId>56a0d47cd328a2.92487658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB4474E0-61CA-4034-A412-A99E122743B8</gtr:id><gtr:title>The contribution of biogerontology to quality ageing</gtr:title><gtr:parentPublicationTitle>Quality in Ageing and Older Adults</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14e8090fe82ea95cf1df6bf07d2bba1a"><gtr:id>14e8090fe82ea95cf1df6bf07d2bba1a</gtr:id><gtr:otherNames>Bagley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>doi_53cfaffaf492fd35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C97BFC3-9F56-4CEE-BA6E-11B902D15AB8</gtr:id><gtr:title>Small molecule inhibition of p38 MAP kinase extends the replicative life span of human ATR-Seckel syndrome fibroblasts.</gtr:title><gtr:parentPublicationTitle>The journals of gerontology. Series A, Biological sciences and medical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d7ee22bdd3e477b3f90b723e16046fd"><gtr:id>4d7ee22bdd3e477b3f90b723e16046fd</gtr:id><gtr:otherNames>Tivey HS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1079-5006</gtr:issn><gtr:outcomeId>pm_53cc01dc01dcc0559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECFF579A-25E3-423E-BB64-19A0D50CA9D1</gtr:id><gtr:title>Ageing science, health care and social inclusion of older people</gtr:title><gtr:parentPublicationTitle>Quality in Ageing and Older Adults</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4f3739d1a2ae7c61233636261a79b252"><gtr:id>4f3739d1a2ae7c61233636261a79b252</gtr:id><gtr:otherNames>Latimer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>doi_53cfaffaf4782218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC38A6D3-3EF0-4627-967B-5DB651CBB14D</gtr:id><gtr:title>The motility of the ethical in bioscience: the case of care in anti-ageing science</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc5551429bf02a8b6d0fbf493c0858db"><gtr:id>fc5551429bf02a8b6d0fbf493c0858db</gtr:id><gtr:otherNames>Joanna Latimer (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_8632972796cb9b386e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>654FD5F2-27E1-4DF9-B5B3-0273A6532E5D</gtr:id><gtr:title>Regiocontrolled synthesis of 3- and 5-aminopyrazoles, pyrazolo[3,4-d]pyrimidines, pyrazolo[3,4-b]pyridines and pyrazolo[3,4-b]quinolinones as MAPK inhibitors</gtr:title><gtr:parentPublicationTitle>Tetrahedron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14e8090fe82ea95cf1df6bf07d2bba1a"><gtr:id>14e8090fe82ea95cf1df6bf07d2bba1a</gtr:id><gtr:otherNames>Bagley M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_53cf94f946726c3d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CD783A3-0749-4DA4-9F3B-78429991E588</gtr:id><gtr:title>The effect of RO3201195 and a pyrazolyl ketone P38 MAPK inhibitor library on the proliferation of Werner syndrome cells.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b56f28666e97438b7e93beed50afe57"><gtr:id>3b56f28666e97438b7e93beed50afe57</gtr:id><gtr:otherNames>Bagley MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>56a0d47c73e261.88616740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60BE49C6-20D2-4EAB-AEBC-A9A7F3C50FE9</gtr:id><gtr:title>The effect of small-molecule inhibition of MAPKAPK2 on cell ageing phenotypes of fibroblasts from human Werner syndrome.</gtr:title><gtr:parentPublicationTitle>Chemistry Central journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e652d93fb2ebe4adce6078cb4fe2f70c"><gtr:id>e652d93fb2ebe4adce6078cb4fe2f70c</gtr:id><gtr:otherNames>Davis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1752-153X</gtr:issn><gtr:outcomeId>doi_53cfabfabb631fcb</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E2A6D31-F5F4-4681-843F-D9DB621889AE</gtr:id><gtr:title>Evaluating the Role of p38 MAPK in the Accelerated Cell Senescence of Werner Syndrome Fibroblasts.</gtr:title><gtr:parentPublicationTitle>Pharmaceuticals (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e652d93fb2ebe4adce6078cb4fe2f70c"><gtr:id>e652d93fb2ebe4adce6078cb4fe2f70c</gtr:id><gtr:otherNames>Davis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1424-8247</gtr:issn><gtr:outcomeId>5aa673df355248.87595894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71771B25-9934-49CF-913B-82D5795D3887</gtr:id><gtr:title>Investigating the role of c-Jun N-terminal kinases in the proliferation of Werner syndrome fibroblasts using diaminopyridine inhibitors.</gtr:title><gtr:parentPublicationTitle>Chemistry Central journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e652d93fb2ebe4adce6078cb4fe2f70c"><gtr:id>e652d93fb2ebe4adce6078cb4fe2f70c</gtr:id><gtr:otherNames>Davis T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1752-153X</gtr:issn><gtr:outcomeId>5aa673df6a3cf9.75734414</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RES">RES-356-25-0024</gtr:identifier><gtr:identifier type="RCUK">ES/G037205/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F0322ED6-113F-4530-BA5E-562216587E68</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Sociology</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>3FB490ED-1150-4B72-BB38-E3A211952C34</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Science &amp; Technology Studies</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F0322ED6-113F-4530-BA5E-562216587E68</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Sociology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>